Myeloma: Hidden Risk in CAR T Prep

Intensive cytotoxic bridging therapy is linked to delayed recovery after CAR T-cell therapy for multiple myeloma.
Medscape Medical News

source https://www.medscape.com/viewarticle/myeloma-hidden-risk-car-t-prep-2025a1000pxo?src=rss